venBio Select Advisor »

Lexeo Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-12-31 $33M 3.3M 9.93

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Structure Therapeutics Sponsored Ads (GPCR)
Avidity Biosciences Common (RNA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celcuity Common (CELC)
Apellis Pharmaceuticals Common (APLS)
Vera Therapeutics Common (VERA)
Spdr Series Trust - S&p Biotech Etf (XBI)
Xenon Pharmaceuticals Common (XENE)

View all positions for venBio Select Advisor

Top funds holding Lexeo Therapeutics

Henderson Group
BlackRock
Paradigm Biocapital Advisors
Vestal Point Capital
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Citadel Advisors
venBio Select Advisor
Affinity Asset Advisors
Woodline Partners
State Street Corporation
Millennium Management
OrbiMed Advisors
Point72 Asset Management

View all funds holding Lexeo Therapeutics